HomayoonKhanlouMD

PubMed

• 36 citations
  Immunomodulation of Antiretroviral Drug-Suppressed Chronic HIV-1 Infection in an Oral Probiotic Double-Blind Placebo-Controlled Trial
  Otto O. Yang, Theodoros Kelesidis, Robert Cordova, Homayoon Khanlou> ;AIDS Research and Human Retroviruses. 2014 Sep 30
• 9 citations
  Documentation of Psychiatric Disorders and Related Factors in a Large Sample Population of HIV-Positive Patients in California
  Iman Parhami, Timothy W. Fong, Aaron Siani, Claudia Carlotti, Homayoon Khanlou> ;AIDS and Behavior. 2013 Oct 1
• SWIFT: Prospective 48 Week Study to Evaluate Efficacy and Safety of Switching to Emtricitibine/Tenofovir from Lamivudine/Abacavir in Virologically Suppressed HIV-1 Inf...
  H Wang, H Khanlou> ;British Journal of Anaesthesia. 2013 Jun
• 140 citations
  Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial†
  Chloe Orkin, Edwin DeJesus, Homayoon Khanlou, Albrecht Stoehr, Khuanchai Supparatpinyo, E Lathouwers, E Lefebvre, M Opsomer, T Van De Casteele, Frank Tomaka> ;HIV Medicine. 2013 Jan 1
• 3 citations
  TMP/SMX is still the preferred empiric antibiotic for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in the HIV population.
  Gina M. Simoncini, Homayoon Khanlou> ;Journal of Acquired Immune Deficiency Syndromes. 2012 Apr 1
• 5 citations
  Similar efficacy of raltegravir when used with or without a protease inhibitor in treatment-experienced patients.
  Daniel J. Skiest, Calvin J. Cohen, Karam Mounzer, Zach Haigney, David Barker, Michael S. Gottlieb, Paul Bellman, Edwin DeJesus, Homayoon Khanlou, Peter Ruane, Chiu-Bin...> ;HIV Clinical Trials. 2011 May 1
• 7 citations
  Clinical impact and cost of laboratory monitoring need review even in resource-rich setting.
  Shilpa Sayana, Marjan Javanbakht, Michael Weinstein, Homayoon Khanlou> ;Journal of Acquired Immune Deficiency Syndromes. 2011 Mar 1
• 1 citations
  The 104 Day Report: A Successful Intervention of Improving Patient Retention
  Shilpa Sayana, Marjan Javanbak, Michael Weinstein, Homayoon Khanlou> ;Clinical Infectious Diseases. 2010 Oct 1
• 1 citations
  DART and laboratory monitoring of HIV treatment.
  Shilpa Sayana, Rishi Manchanda, Homayoon Khanlou, Jorge Saavedra, Peter Reis, Michael Weinstein> ;Lancet. 2010 Mar 20
• 3 citations
  An unusual pathogen for a liver abscess in a human immunodeficiency virus-infected individual.
  Shilpa Sayana, Juan-Carlos Ricaurte, Homayoon Khanlou> ;The American Journal of the Medical Sciences. 2010 Mar 1
• Avoid a different standard of care when applying results of Development of Antiretroviral Therapy in Africa (DART) study.
  Shilpa Sayana, Rishi Manchanda, Homayoon Khanlou, Jorge Saavedra, Peter Reis, Michael Weinstein> ;Journal of Acquired Immune Deficiency Syndromes. 2010 Jan 1
• 180 citations
  Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells
  Ronald T. Mitsuyasu, Thomas C. Merigan, Andrew Carr, Jerome A. Zack, Mark A. Winters, Cassy Workman, Mark Bloch, Jacob Lalezari, Stephen Becker, Lorna Thornton, Bisher...> ;Nature Medicine. 2009 Mar 1
• 46 citations
  Maraviroc: a new CCR5 antagonist.
  Shilpa Sayana, Homayoon Khanlou> ;Expert Review of Anti-Infective Therapy. 2009 Feb 1
• 7 citations
  Raltegravir: the first in a new class of integrase inhibitors for the treatment of HIV.
  Shilpa Sayana, Homayoon Khanlou> ;Expert Review of Anti-Infective Therapy. 2008 Aug 1
• 4 citations
  False-positivity of HIV-2 immunoblots in a cohort of elite suppressors infected with HIV-1.
  Mehri S McKellar, Pam Jongthavorn, Homayoon Khanlou> ;Journal of Acquired Immune Deficiency Syndromes. 2008 Apr 15
• 22 citations
  The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients.
  Homayoon Khanlou, Susan Sanchez, Michele Babaie, Catherine Chien, Gerald Hamwi, Juan-Carlos Ricaurte, Tomiko Stein, Laveeza Bhatti, Paul Denouden, Charles Farthing> ;Archives of Internal Medicine. 2006 Jul 10
• 9 citations
  Safety and efficacy of heliox as a treatment for upper airway obstruction due to radiation-induced laryngeal dysfunction*
  Homayoun Khanlou, Glenn Eiger> ;Heart & Lung. 2001 Mar 1
• 13 citations
  Long-term remission of refractory stiff-man syndrome after treatment with intravenous immunoglobulin.
  Homayoun Khanlou, Glenn Eiger> ;Mayo Clinic Proceedings. 1999 Dec 1
• 3 citations
  Massive Subfascial Hematoma After Alteplase Therapy for Acute Myocardial Infarction
  Homayoun Khanlou, Gaurav Malhotra, Nehgar Khanlou, Glenn Eiger, Peter Frechie> ;The American Journal of the Medical Sciences. 1999 Jan 1
• 14 citations
  Fatal alveolar hemorrhage and Abciximab (ReoProTM) therapy for acute myocardial infarction
  Homayoun Khanlou, Sotirios Tsiodras, Glenn Eiger, Khalid Abousy, Steven K. Goldberg, Fred K. Nakhjavan, Shahriar Yazdanfar> ;Catheterization and Cardiovascular Diagnosis. 1998 Jul 1
• Idiopathic adulthood ductopenia: case report and review of the literature.
  Khanlou, H., Sass, D., Rothstein, K., Manzarbeitia, C., Reich, D., Jacobson, L., Fleischer, D., Muñoz, S. J.> ;Arch Intern Med. 2000 Apr 10
• Resolution of adult respiratory distress syndrome after recovery from fulminant hepatic failure.
  Khanlou, H., Souto, H., Lippmann, M., Muñoz, S., Rothstein, K., Ozden, Z.> ;Am J Med Sci. 1999 Feb
• Abciximab and alveolar hemorrhage.
  Khanlou, H., Eiger, G., Yazdanfar, S.> ;N Engl J Med. 1998 Dec 17
• Jejunal telangiectasias as a cause of massive bleeding in a patient with scleroderma.
  Khanlou, H., Malhotra, A., Friedenberg, F., Rothstein, K.> ;Rev Rhum Engl Ed. 1999 Feb
• Schwannoma of posterior mediastinum: a case report and concise review.
  Khanlou, H., Khanlou, N., Eiger, G.> ;Heart Lung. 1998 Sep 01
• Join now to see all